

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.21566591 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.08352337 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.76907639 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.58117022 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.43797263 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.38797200 |
| 7 | glutamate secretion (GO:0014047) | 5.28078677 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.26759558 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.24885836 |
| 10 | vocalization behavior (GO:0071625) | 5.22391279 |
| 11 | atrial cardiac muscle cell action potential (GO:0086014) | 5.17385118 |
| 12 | kidney morphogenesis (GO:0060993) | 4.96054609 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.86524990 |
| 14 | regulation of synaptic vesicle transport (GO:1902803) | 4.79603590 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.69445105 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.47687567 |
| 17 | urinary tract smooth muscle contraction (GO:0014848) | 4.46300036 |
| 18 | protein localization to synapse (GO:0035418) | 4.43201123 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.28764344 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.25956034 |
| 21 | exploration behavior (GO:0035640) | 4.23984903 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.22434572 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 4.19876604 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.18513085 |
| 25 | behavioral response to nicotine (GO:0035095) | 4.16871003 |
| 26 | layer formation in cerebral cortex (GO:0021819) | 4.09159606 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.07800109 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.02207888 |
| 29 | regulation of respiratory system process (GO:0044065) | 3.98590823 |
| 30 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.97692443 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.97058135 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 3.93977215 |
| 33 | dendritic spine morphogenesis (GO:0060997) | 3.90580365 |
| 34 | peristalsis (GO:0030432) | 3.83946360 |
| 35 | pseudouridine synthesis (GO:0001522) | 3.82931855 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.79687650 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.76985699 |
| 38 | protein polyglutamylation (GO:0018095) | 3.76313248 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 3.75540268 |
| 40 | long-term memory (GO:0007616) | 3.72592806 |
| 41 | neuron-neuron synaptic transmission (GO:0007270) | 3.70225988 |
| 42 | glutamate receptor signaling pathway (GO:0007215) | 3.68842305 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.64683862 |
| 44 | activation of protein kinase A activity (GO:0034199) | 3.62131445 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.59147689 |
| 46 | proline transport (GO:0015824) | 3.58823157 |
| 47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.58796347 |
| 48 | neurotransmitter transport (GO:0006836) | 3.57409608 |
| 49 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.56657598 |
| 50 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.49297700 |
| 51 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.46579676 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.45381717 |
| 53 | regulation of neurotransmitter secretion (GO:0046928) | 3.41731215 |
| 54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.38459841 |
| 55 | regulation of synaptic plasticity (GO:0048167) | 3.37752414 |
| 56 | glycerophospholipid catabolic process (GO:0046475) | 3.36614114 |
| 57 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.36465094 |
| 58 | sodium ion export (GO:0071436) | 3.34960898 |
| 59 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.32348181 |
| 60 | nucleobase catabolic process (GO:0046113) | 3.31792701 |
| 61 | dendrite morphogenesis (GO:0048813) | 3.30254617 |
| 62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.28826954 |
| 63 | auditory behavior (GO:0031223) | 3.28508073 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 3.28457735 |
| 65 | neuromuscular process controlling balance (GO:0050885) | 3.28225440 |
| 66 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.28202821 |
| 67 | positive regulation of neurotransmitter transport (GO:0051590) | 3.27257327 |
| 68 | regulation of microtubule-based movement (GO:0060632) | 3.26945567 |
| 69 | postsynaptic membrane organization (GO:0001941) | 3.26747291 |
| 70 | nitric oxide biosynthetic process (GO:0006809) | 3.25753027 |
| 71 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.24893643 |
| 72 | regulation of ARF protein signal transduction (GO:0032012) | 3.23796872 |
| 73 | response to auditory stimulus (GO:0010996) | 3.22697827 |
| 74 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.22212907 |
| 75 | regulation of vesicle fusion (GO:0031338) | 3.19601402 |
| 76 | negative regulation of telomere maintenance (GO:0032205) | 3.18785252 |
| 77 | adult feeding behavior (GO:0008343) | 3.18531518 |
| 78 | glycine transport (GO:0015816) | 3.18296124 |
| 79 | transmission of nerve impulse (GO:0019226) | 3.18045102 |
| 80 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.16857555 |
| 81 | neuromuscular process controlling posture (GO:0050884) | 3.16457377 |
| 82 | cell communication by electrical coupling (GO:0010644) | 3.16190550 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.15676302 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14904333 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 3.14597375 |
| 86 | regulation of respiratory gaseous exchange (GO:0043576) | 3.13230884 |
| 87 | prepulse inhibition (GO:0060134) | 3.13206365 |
| 88 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.13196435 |
| 89 | long-term synaptic potentiation (GO:0060291) | 3.12532476 |
| 90 | neuron recognition (GO:0008038) | 3.12239323 |
| 91 | membrane hyperpolarization (GO:0060081) | 3.08987396 |
| 92 | positive regulation of synapse maturation (GO:0090129) | 3.08904599 |
| 93 | regulation of telomere maintenance (GO:0032204) | 3.08815969 |
| 94 | myotube differentiation (GO:0014902) | 3.08667206 |
| 95 | positive regulation of respiratory burst (GO:0060267) | 3.07157733 |
| 96 | synaptic vesicle endocytosis (GO:0048488) | 3.05156093 |
| 97 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.03666266 |
| 98 | regulation of guanylate cyclase activity (GO:0031282) | 3.03181810 |
| 99 | presynaptic membrane assembly (GO:0097105) | 3.02552992 |
| 100 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.99531044 |
| 101 | neuronal ion channel clustering (GO:0045161) | 2.99237385 |
| 102 | chemosensory behavior (GO:0007635) | 2.99131813 |
| 103 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.98673577 |
| 104 | detection of light stimulus involved in visual perception (GO:0050908) | 2.98673577 |
| 105 | DNA deamination (GO:0045006) | 2.95543814 |
| 106 | dendritic spine organization (GO:0097061) | 2.94413106 |
| 107 | vesicle transport along microtubule (GO:0047496) | 2.92289233 |
| 108 | membrane depolarization (GO:0051899) | 2.91886157 |
| 109 | membrane depolarization during action potential (GO:0086010) | 2.89968542 |
| 110 | positive regulation of synaptic transmission (GO:0050806) | 2.89762641 |
| 111 | epithelial cilium movement (GO:0003351) | 2.89731028 |
| 112 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.89683778 |
| 113 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.88451253 |
| 114 | axonal fasciculation (GO:0007413) | 2.87870733 |
| 115 | neuronal action potential (GO:0019228) | 2.87549671 |
| 116 | innervation (GO:0060384) | 2.86870125 |
| 117 | synapse assembly (GO:0007416) | 2.86313507 |
| 118 | fucose catabolic process (GO:0019317) | 2.85842228 |
| 119 | L-fucose metabolic process (GO:0042354) | 2.85842228 |
| 120 | L-fucose catabolic process (GO:0042355) | 2.85842228 |
| 121 | serotonin metabolic process (GO:0042428) | 2.85119298 |
| 122 | piRNA metabolic process (GO:0034587) | 2.84798828 |
| 123 | sulfate transport (GO:0008272) | 2.84558071 |
| 124 | presynaptic membrane organization (GO:0097090) | 2.84017896 |
| 125 | regulation of synaptic transmission (GO:0050804) | 2.83599517 |
| 126 | learning (GO:0007612) | 2.81887897 |
| 127 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.78789520 |
| 128 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.78715628 |
| 129 | neuromuscular process (GO:0050905) | 2.78418592 |
| 130 | synaptic transmission (GO:0007268) | 2.78356463 |
| 131 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.77620777 |
| 132 | ketone body metabolic process (GO:1902224) | 2.77208091 |
| 133 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.76993280 |
| 134 | regulation of dendritic spine development (GO:0060998) | 2.76876312 |
| 135 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.76415094 |
| 136 | primary amino compound metabolic process (GO:1901160) | 2.76210107 |
| 137 | phasic smooth muscle contraction (GO:0014821) | 2.76005666 |
| 138 | positive regulation of dendritic spine development (GO:0060999) | 2.75954854 |
| 139 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.75783905 |
| 140 | regulation of synapse assembly (GO:0051963) | 2.74914719 |
| 141 | cell migration in hindbrain (GO:0021535) | 2.74666745 |
| 142 | social behavior (GO:0035176) | 2.74499881 |
| 143 | intraspecies interaction between organisms (GO:0051703) | 2.74499881 |
| 144 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.73078373 |
| 145 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.71914522 |
| 146 | cilium movement (GO:0003341) | 2.70110722 |
| 147 | growth hormone secretion (GO:0030252) | 2.69418918 |
| 148 | cornea development in camera-type eye (GO:0061303) | 2.67346669 |
| 149 | sympathetic nervous system development (GO:0048485) | 2.62372371 |
| 150 | nonmotile primary cilium assembly (GO:0035058) | 2.60988803 |
| 151 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.59641604 |
| 152 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.58605916 |
| 153 | regulation of neurotransmitter uptake (GO:0051580) | 2.54347448 |
| 154 | action potential (GO:0001508) | 2.53696905 |
| 155 | multicellular organismal movement (GO:0050879) | 2.53657412 |
| 156 | musculoskeletal movement (GO:0050881) | 2.53657412 |
| 157 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.52677431 |
| 158 | response to nitrosative stress (GO:0051409) | 2.52256635 |
| 159 | protein localization to cilium (GO:0061512) | 2.52242408 |
| 160 | neuron fate specification (GO:0048665) | 2.50042513 |
| 161 | regulation of action potential (GO:0098900) | 2.48644828 |
| 162 | startle response (GO:0001964) | 2.45553768 |
| 163 | gap junction assembly (GO:0016264) | 2.45182574 |
| 164 | axoneme assembly (GO:0035082) | 2.45106090 |
| 165 | peptidyl-cysteine modification (GO:0018198) | 2.44745298 |
| 166 | insulin secretion (GO:0030073) | 2.44331244 |
| 167 | positive regulation of synapse assembly (GO:0051965) | 2.42557188 |
| 168 | biotin metabolic process (GO:0006768) | 2.38909836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.42634817 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.21526718 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.97920029 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.95320188 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.85067892 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.67008410 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65290161 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65290161 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64835346 |
| 10 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.60058775 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.58872577 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.53171115 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51555578 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46574828 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45183055 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35923490 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35289828 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.30311195 |
| 19 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29275202 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26988258 |
| 21 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.23915077 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23808915 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19394636 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12067624 |
| 25 | FUS_26573619_Chip-Seq_HEK293_Human | 2.07411298 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.02385700 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.99900529 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96391277 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.96365642 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.95567813 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91280211 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.87725514 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85602571 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83701298 |
| 35 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.79627141 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79005898 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.74669735 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.58579384 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57529370 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53753733 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53285808 |
| 42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52365505 |
| 43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46069375 |
| 44 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.44687344 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.43992799 |
| 46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43582165 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37291203 |
| 48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37291203 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.36928275 |
| 50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36375177 |
| 51 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.34898823 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34450185 |
| 53 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.33970120 |
| 54 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.33543443 |
| 55 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.33364942 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31027981 |
| 57 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.30339729 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30226776 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29448171 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29039466 |
| 61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.28102231 |
| 62 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26956729 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26891344 |
| 64 | AR_19668381_ChIP-Seq_PC3_Human | 1.26698474 |
| 65 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26164418 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26003088 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24077290 |
| 68 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21382071 |
| 69 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.21150703 |
| 70 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21050663 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20360959 |
| 72 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18058398 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17379310 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16608133 |
| 75 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16249232 |
| 76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15916760 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15286936 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15278904 |
| 79 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.14529926 |
| 80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.14069780 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13652307 |
| 82 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13334910 |
| 83 | ERA_21632823_ChIP-Seq_H3396_Human | 1.12248932 |
| 84 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12043816 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11263639 |
| 86 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11038209 |
| 87 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10308838 |
| 88 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09970337 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09354406 |
| 90 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08746345 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07859516 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07684425 |
| 93 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.07412061 |
| 94 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.07412061 |
| 95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07384917 |
| 96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04790121 |
| 97 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04483296 |
| 98 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04376066 |
| 99 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04236682 |
| 100 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03675122 |
| 101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03613184 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03194248 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02832434 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02613940 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02538759 |
| 106 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02349065 |
| 107 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01008267 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00749963 |
| 109 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00688510 |
| 110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00474631 |
| 111 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00426201 |
| 112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00002224 |
| 113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99735045 |
| 114 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99352170 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97248050 |
| 116 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96645676 |
| 117 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.95895622 |
| 118 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95805913 |
| 119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95173383 |
| 120 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94748313 |
| 121 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94532057 |
| 122 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93156076 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91886969 |
| 124 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90790173 |
| 125 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90123989 |
| 126 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89902854 |
| 127 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89491034 |
| 128 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89403072 |
| 129 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88373314 |
| 130 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87937723 |
| 131 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87868384 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86669063 |
| 133 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86068554 |
| 134 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85189797 |
| 135 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84139315 |
| 136 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83368976 |
| 137 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83353142 |
| 138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83327733 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82336339 |
| 140 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81629753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.45491467 |
| 2 | MP0003880_abnormal_central_pattern | 4.24679948 |
| 3 | MP0004147_increased_porphyrin_level | 4.11402072 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.08832790 |
| 5 | MP0004270_analgesia | 3.78973277 |
| 6 | MP0009745_abnormal_behavioral_response | 3.31777570 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.25184308 |
| 8 | MP0002822_catalepsy | 3.10572634 |
| 9 | MP0002064_seizures | 3.04634002 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.95921278 |
| 11 | MP0009046_muscle_twitch | 2.90849561 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.81429227 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.80820850 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.72288971 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.67931538 |
| 16 | MP0001486_abnormal_startle_reflex | 2.65734819 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.62082437 |
| 18 | MP0001348_abnormal_lacrimal_gland | 2.61229818 |
| 19 | MP0002272_abnormal_nervous_system | 2.53473042 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.25727042 |
| 21 | MP0003646_muscle_fatigue | 2.21854328 |
| 22 | MP0002909_abnormal_adrenal_gland | 2.09000924 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.08942935 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.04981582 |
| 25 | MP0005646_abnormal_pituitary_gland | 2.00585756 |
| 26 | MP0002736_abnormal_nociception_after | 2.00050983 |
| 27 | MP0002735_abnormal_chemical_nociception | 1.98642333 |
| 28 | MP0003195_calcinosis | 1.95277868 |
| 29 | MP0001970_abnormal_pain_threshold | 1.94739249 |
| 30 | MP0003879_abnormal_hair_cell | 1.92331524 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.86873583 |
| 32 | MP0008569_lethality_at_weaning | 1.86778103 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.86466260 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.85046793 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.81303103 |
| 36 | MP0000427_abnormal_hair_cycle | 1.77679640 |
| 37 | MP0001984_abnormal_olfaction | 1.76531235 |
| 38 | MP0004858_abnormal_nervous_system | 1.75824568 |
| 39 | MP0004885_abnormal_endolymph | 1.72141094 |
| 40 | MP0002184_abnormal_innervation | 1.72098396 |
| 41 | MP0003329_amyloid_beta_deposits | 1.71164407 |
| 42 | MP0004924_abnormal_behavior | 1.67478467 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.67478467 |
| 44 | MP0000778_abnormal_nervous_system | 1.64362963 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.58741221 |
| 46 | MP0000383_abnormal_hair_follicle | 1.57323418 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.50948443 |
| 48 | MP0000955_abnormal_spinal_cord | 1.50821909 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.50717045 |
| 50 | MP0004133_heterotaxia | 1.45925913 |
| 51 | MP0002102_abnormal_ear_morphology | 1.43861745 |
| 52 | MP0002882_abnormal_neuron_morphology | 1.42043991 |
| 53 | MP0003633_abnormal_nervous_system | 1.39508614 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.38032840 |
| 55 | MP0002066_abnormal_motor_capabilities/c | 1.36441025 |
| 56 | MP0003137_abnormal_impulse_conducting | 1.34522029 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.31780380 |
| 58 | MP0008961_abnormal_basal_metabolism | 1.31156915 |
| 59 | MP0003787_abnormal_imprinting | 1.29886174 |
| 60 | MP0003890_abnormal_embryonic-extraembry | 1.24216368 |
| 61 | MP0005379_endocrine/exocrine_gland_phen | 1.22684444 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19696962 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.18695720 |
| 64 | MP0010678_abnormal_skin_adnexa | 1.17354676 |
| 65 | MP0009840_abnormal_foam_cell | 1.12606637 |
| 66 | MP0002229_neurodegeneration | 1.11251750 |
| 67 | MP0004742_abnormal_vestibular_system | 1.09813839 |
| 68 | MP0003631_nervous_system_phenotype | 1.08162712 |
| 69 | MP0001177_atelectasis | 1.08070324 |
| 70 | MP0005394_taste/olfaction_phenotype | 1.07149141 |
| 71 | MP0005499_abnormal_olfactory_system | 1.07149141 |
| 72 | MP0004043_abnormal_pH_regulation | 1.06418541 |
| 73 | MP0000013_abnormal_adipose_tissue | 1.04938903 |
| 74 | MP0003283_abnormal_digestive_organ | 1.04843823 |
| 75 | MP0001529_abnormal_vocalization | 1.00255428 |
| 76 | MP0002160_abnormal_reproductive_system | 0.99404525 |
| 77 | MP0002152_abnormal_brain_morphology | 0.99257383 |
| 78 | MP0008872_abnormal_physiological_respon | 0.99228888 |
| 79 | MP0002751_abnormal_autonomic_nervous | 0.97788650 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.97314813 |
| 81 | MP0005535_abnormal_body_temperature | 0.96304458 |
| 82 | MP0001905_abnormal_dopamine_level | 0.95851239 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.94982557 |
| 84 | MP0005448_abnormal_energy_balance | 0.94312011 |
| 85 | MP0004142_abnormal_muscle_tone | 0.92682883 |
| 86 | MP0001944_abnormal_pancreas_morphology | 0.90230932 |
| 87 | MP0003075_altered_response_to | 0.89941806 |
| 88 | MP0008874_decreased_physiological_sensi | 0.88322891 |
| 89 | MP0001188_hyperpigmentation | 0.86016480 |
| 90 | MP0005248_abnormal_Harderian_gland | 0.85287454 |
| 91 | MP0003690_abnormal_glial_cell | 0.84816473 |
| 92 | MP0003122_maternal_imprinting | 0.84711748 |
| 93 | MP0001664_abnormal_digestion | 0.82939820 |
| 94 | MP0002090_abnormal_vision | 0.82861435 |
| 95 | MP0006072_abnormal_retinal_apoptosis | 0.80981904 |
| 96 | MP0000604_amyloidosis | 0.80102403 |
| 97 | MP0003634_abnormal_glial_cell | 0.78460595 |
| 98 | MP0002254_reproductive_system_inflammat | 0.77945683 |
| 99 | MP0001919_abnormal_reproductive_system | 0.77820351 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.77761166 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 0.77621576 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.76218169 |
| 103 | MP0003718_maternal_effect | 0.75847474 |
| 104 | MP0001963_abnormal_hearing_physiology | 0.75648064 |
| 105 | MP0004085_abnormal_heartbeat | 0.75263882 |
| 106 | MP0001485_abnormal_pinna_reflex | 0.73274267 |
| 107 | MP0002752_abnormal_somatic_nervous | 0.72602906 |
| 108 | MP0003953_abnormal_hormone_level | 0.71590634 |
| 109 | MP0005195_abnormal_posterior_eye | 0.70900730 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.70892074 |
| 111 | MP0003121_genomic_imprinting | 0.70796647 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.70582455 |
| 113 | MP0003632_abnormal_nervous_system | 0.67487447 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.67194330 |
| 115 | MP0004145_abnormal_muscle_electrophysio | 0.67007505 |
| 116 | MP0005253_abnormal_eye_physiology | 0.66921216 |
| 117 | MP0010234_abnormal_vibrissa_follicle | 0.66892009 |
| 118 | MP0000920_abnormal_myelination | 0.64248039 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.61178304 |
| 120 | MP0005187_abnormal_penis_morphology | 0.59696346 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.59409595 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.50936988 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.50549471 |
| 124 | MP0001943_abnormal_respiration | 0.49355085 |
| 125 | MP0003956_abnormal_body_size | 0.49302969 |
| 126 | MP0010769_abnormal_survival | 0.49143049 |
| 127 | MP0005409_darkened_coat_color | 0.48800909 |
| 128 | MP0002082_postnatal_lethality | 0.48473907 |
| 129 | MP0010770_preweaning_lethality | 0.48473907 |
| 130 | MP0001299_abnormal_eye_distance/ | 0.48301875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 7.25973994 |
| 2 | Focal motor seizures (HP:0011153) | 7.09130566 |
| 3 | Myokymia (HP:0002411) | 6.88023824 |
| 4 | Focal seizures (HP:0007359) | 5.51011841 |
| 5 | Visual hallucinations (HP:0002367) | 5.10416557 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.62577953 |
| 7 | Breast hypoplasia (HP:0003187) | 4.42311827 |
| 8 | Atonic seizures (HP:0010819) | 4.25943328 |
| 9 | Febrile seizures (HP:0002373) | 4.23804097 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.02977318 |
| 11 | Action tremor (HP:0002345) | 3.99701550 |
| 12 | Microretrognathia (HP:0000308) | 3.94711421 |
| 13 | Absence seizures (HP:0002121) | 3.91762200 |
| 14 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 3.89555563 |
| 15 | Type II lissencephaly (HP:0007260) | 3.81119841 |
| 16 | Ankle clonus (HP:0011448) | 3.72262252 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.71362886 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.65376459 |
| 19 | Pancreatic cysts (HP:0001737) | 3.62415310 |
| 20 | Poor eye contact (HP:0000817) | 3.55981625 |
| 21 | Dialeptic seizures (HP:0011146) | 3.49668476 |
| 22 | Congenital stationary night blindness (HP:0007642) | 3.44045476 |
| 23 | Broad-based gait (HP:0002136) | 3.34839011 |
| 24 | Papilledema (HP:0001085) | 3.29982129 |
| 25 | Abnormal social behavior (HP:0012433) | 3.28694906 |
| 26 | Impaired social interactions (HP:0000735) | 3.28694906 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 3.27827253 |
| 28 | Lissencephaly (HP:0001339) | 3.24491713 |
| 29 | Depression (HP:0000716) | 3.22146501 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.16458467 |
| 31 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.11801316 |
| 32 | True hermaphroditism (HP:0010459) | 3.08319627 |
| 33 | Gait imbalance (HP:0002141) | 3.05155049 |
| 34 | Truncal ataxia (HP:0002078) | 3.04269379 |
| 35 | Patellar aplasia (HP:0006443) | 3.03902101 |
| 36 | Pancreatic fibrosis (HP:0100732) | 3.03178678 |
| 37 | Anxiety (HP:0000739) | 3.01193665 |
| 38 | Protruding tongue (HP:0010808) | 2.99460938 |
| 39 | Nephronophthisis (HP:0000090) | 2.98830267 |
| 40 | Hyperventilation (HP:0002883) | 2.98559097 |
| 41 | Postural instability (HP:0002172) | 2.97838069 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.97555487 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.95116955 |
| 44 | Dysmetria (HP:0001310) | 2.89874359 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 2.88105289 |
| 46 | Molar tooth sign on MRI (HP:0002419) | 2.88105289 |
| 47 | Long foot (HP:0001833) | 2.87388585 |
| 48 | Torticollis (HP:0000473) | 2.85907699 |
| 49 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.85699191 |
| 50 | Medial flaring of the eyebrow (HP:0010747) | 2.82245712 |
| 51 | Mutism (HP:0002300) | 2.78154936 |
| 52 | Genetic anticipation (HP:0003743) | 2.76419768 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.75013405 |
| 54 | Amblyopia (HP:0000646) | 2.74610852 |
| 55 | Congenital primary aphakia (HP:0007707) | 2.74301734 |
| 56 | Agitation (HP:0000713) | 2.74201494 |
| 57 | Abnormal eating behavior (HP:0100738) | 2.72214459 |
| 58 | Scanning speech (HP:0002168) | 2.67220530 |
| 59 | Urinary urgency (HP:0000012) | 2.66529571 |
| 60 | Abnormality of the renal cortex (HP:0011035) | 2.63480049 |
| 61 | Megalencephaly (HP:0001355) | 2.62823436 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 2.62699253 |
| 63 | Focal dystonia (HP:0004373) | 2.61896861 |
| 64 | Abnormality of the renal medulla (HP:0100957) | 2.61591385 |
| 65 | Spastic gait (HP:0002064) | 2.61375968 |
| 66 | Intention tremor (HP:0002080) | 2.59485078 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.59319963 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.55600915 |
| 69 | Stereotypic behavior (HP:0000733) | 2.53775035 |
| 70 | Drooling (HP:0002307) | 2.53016636 |
| 71 | Excessive salivation (HP:0003781) | 2.53016636 |
| 72 | Hypsarrhythmia (HP:0002521) | 2.50712326 |
| 73 | Scrotal hypoplasia (HP:0000046) | 2.49338339 |
| 74 | Limb dystonia (HP:0002451) | 2.45745764 |
| 75 | Neurofibrillary tangles (HP:0002185) | 2.45379438 |
| 76 | Status epilepticus (HP:0002133) | 2.44291580 |
| 77 | Poor speech (HP:0002465) | 2.40824037 |
| 78 | Bradykinesia (HP:0002067) | 2.40307629 |
| 79 | Hemiplegia (HP:0002301) | 2.39707474 |
| 80 | Large for gestational age (HP:0001520) | 2.39463710 |
| 81 | Craniofacial dystonia (HP:0012179) | 2.37972194 |
| 82 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.35744512 |
| 83 | Dysmetric saccades (HP:0000641) | 2.35630566 |
| 84 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.33160728 |
| 85 | Macroorchidism (HP:0000053) | 2.32000531 |
| 86 | Hemiparesis (HP:0001269) | 2.29579470 |
| 87 | Tubular atrophy (HP:0000092) | 2.29137958 |
| 88 | Widely spaced teeth (HP:0000687) | 2.28718379 |
| 89 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.28064190 |
| 90 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.28064190 |
| 91 | Diastasis recti (HP:0001540) | 2.27854661 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 2.25998544 |
| 93 | Impaired vibratory sensation (HP:0002495) | 2.25131823 |
| 94 | Abnormal ciliary motility (HP:0012262) | 2.22828891 |
| 95 | Poor coordination (HP:0002370) | 2.22114538 |
| 96 | Abnormality of binocular vision (HP:0011514) | 2.21833076 |
| 97 | Diplopia (HP:0000651) | 2.21833076 |
| 98 | Absent speech (HP:0001344) | 2.21715297 |
| 99 | Progressive inability to walk (HP:0002505) | 2.19337750 |
| 100 | Ventricular fibrillation (HP:0001663) | 2.18811380 |
| 101 | Pachygyria (HP:0001302) | 2.17185367 |
| 102 | Genital tract atresia (HP:0001827) | 2.15746806 |
| 103 | Pendular nystagmus (HP:0012043) | 2.15324224 |
| 104 | Retinal dysplasia (HP:0007973) | 2.15000495 |
| 105 | Pheochromocytoma (HP:0002666) | 2.14397143 |
| 106 | Annular pancreas (HP:0001734) | 2.14366047 |
| 107 | Clonus (HP:0002169) | 2.13189010 |
| 108 | Vaginal atresia (HP:0000148) | 2.13083291 |
| 109 | Blue irides (HP:0000635) | 2.12295358 |
| 110 | Concave nail (HP:0001598) | 2.11521907 |
| 111 | Chorioretinal atrophy (HP:0000533) | 2.10965104 |
| 112 | Cystic liver disease (HP:0006706) | 2.10925816 |
| 113 | Lower limb muscle weakness (HP:0007340) | 2.06808060 |
| 114 | Insidious onset (HP:0003587) | 2.06713783 |
| 115 | Termporal pattern (HP:0011008) | 2.06713783 |
| 116 | Central scotoma (HP:0000603) | 2.06142079 |
| 117 | Depressed nasal tip (HP:0000437) | 2.05638306 |
| 118 | Generalized myoclonic seizures (HP:0002123) | 2.05459193 |
| 119 | Attenuation of retinal blood vessels (HP:0007843) | 2.05250625 |
| 120 | Insomnia (HP:0100785) | 2.04452212 |
| 121 | Hypothermia (HP:0002045) | 2.04152689 |
| 122 | Chronic hepatic failure (HP:0100626) | 2.02097580 |
| 123 | Abnormality of the corticospinal tract (HP:0002492) | 2.01280962 |
| 124 | Optic nerve hypoplasia (HP:0000609) | 2.01261457 |
| 125 | Decreased circulating renin level (HP:0003351) | 2.00541637 |
| 126 | Gait ataxia (HP:0002066) | 1.96932610 |
| 127 | Pointed chin (HP:0000307) | 1.95774167 |
| 128 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.95369572 |
| 129 | Severe muscular hypotonia (HP:0006829) | 1.94747087 |
| 130 | Inability to walk (HP:0002540) | 1.94040684 |
| 131 | Large eyes (HP:0001090) | 1.92865158 |
| 132 | Resting tremor (HP:0002322) | 1.91877157 |
| 133 | Hip dysplasia (HP:0001385) | 1.87029585 |
| 134 | Bundle branch block (HP:0011710) | 1.85486786 |
| 135 | Microtia (HP:0008551) | 1.84483896 |
| 136 | Spinal canal stenosis (HP:0003416) | 1.83909587 |
| 137 | Fetal akinesia sequence (HP:0001989) | 1.82325006 |
| 138 | Cerebellar dysplasia (HP:0007033) | 1.81785195 |
| 139 | Abnormal EKG (HP:0003115) | 1.81531359 |
| 140 | Polyphagia (HP:0002591) | 1.81376652 |
| 141 | Anencephaly (HP:0002323) | 1.81055646 |
| 142 | Abnormality of saccadic eye movements (HP:0000570) | 1.81041375 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.79732520 |
| 144 | Progressive microcephaly (HP:0000253) | 1.79643973 |
| 145 | Sclerocornea (HP:0000647) | 1.79599949 |
| 146 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.79261748 |
| 147 | Abnormality of macular pigmentation (HP:0008002) | 1.79088813 |
| 148 | Furrowed tongue (HP:0000221) | 1.77837138 |
| 149 | Amyotrophic lateral sclerosis (HP:0007354) | 1.77701385 |
| 150 | Postural tremor (HP:0002174) | 1.76346461 |
| 151 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.76278256 |
| 152 | Psychosis (HP:0000709) | 1.76259483 |
| 153 | Obstructive sleep apnea (HP:0002870) | 1.76212001 |
| 154 | Rigidity (HP:0002063) | 1.75978891 |
| 155 | Abnormality of the clitoris (HP:0000056) | 1.75663280 |
| 156 | Failure to thrive in infancy (HP:0001531) | 1.75282121 |
| 157 | Dyskinesia (HP:0100660) | 1.74671727 |
| 158 | Abnormality of the vitreous humor (HP:0004327) | 1.74343227 |
| 159 | Abnormal biliary tract physiology (HP:0012439) | 1.73456805 |
| 160 | Bile duct proliferation (HP:0001408) | 1.73456805 |
| 161 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.73406133 |
| 162 | Aplasia of the phalanges of the hand (HP:0009802) | 1.73406133 |
| 163 | Aplasia involving bones of the extremities (HP:0009825) | 1.73406133 |
| 164 | Female pseudohermaphroditism (HP:0010458) | 1.73206307 |
| 165 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.72571106 |
| 166 | Absent/shortened dynein arms (HP:0200106) | 1.72275534 |
| 167 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.72275534 |
| 168 | Incomplete penetrance (HP:0003829) | 1.71971723 |
| 169 | Slender long bone (HP:0003100) | 1.71686162 |
| 170 | Neuroendocrine neoplasm (HP:0100634) | 1.71281380 |
| 171 | Abolished electroretinogram (ERG) (HP:0000550) | 1.69988517 |
| 172 | Hypoplasia of the brainstem (HP:0002365) | 1.68002403 |
| 173 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.68002403 |
| 174 | Oligodactyly (hands) (HP:0001180) | 1.65886429 |
| 175 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.65795410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 5.29502665 |
| 2 | BMPR1B | 4.23158649 |
| 3 | NTRK3 | 4.20247035 |
| 4 | MAP3K9 | 4.09310561 |
| 5 | EPHA4 | 4.03241036 |
| 6 | FRK | 3.60579790 |
| 7 | MARK1 | 3.30092391 |
| 8 | MAP3K4 | 2.89923775 |
| 9 | DAPK2 | 2.88543969 |
| 10 | MINK1 | 2.54664584 |
| 11 | MAP2K7 | 2.48471443 |
| 12 | PRKD3 | 2.26259048 |
| 13 | PAK6 | 2.22499005 |
| 14 | NTRK2 | 2.18463825 |
| 15 | CAMKK1 | 2.11030320 |
| 16 | KSR2 | 1.96613504 |
| 17 | NTRK1 | 1.92562820 |
| 18 | ADRBK2 | 1.90847397 |
| 19 | MAP2K4 | 1.90512694 |
| 20 | NME1 | 1.83879819 |
| 21 | TGFBR1 | 1.78114869 |
| 22 | ZAK | 1.77675086 |
| 23 | MAP3K2 | 1.75767869 |
| 24 | CAMK1D | 1.75470390 |
| 25 | CDK5 | 1.63054598 |
| 26 | MAP3K12 | 1.56786207 |
| 27 | KSR1 | 1.56244559 |
| 28 | DAPK1 | 1.49339549 |
| 29 | STK39 | 1.48003335 |
| 30 | CASK | 1.43367302 |
| 31 | CAMKK2 | 1.43214626 |
| 32 | GRK1 | 1.40744387 |
| 33 | TAOK1 | 1.37321414 |
| 34 | SIK2 | 1.36988158 |
| 35 | MAPK13 | 1.36134908 |
| 36 | CDK19 | 1.35717079 |
| 37 | STK38 | 1.35312629 |
| 38 | TYRO3 | 1.32255331 |
| 39 | MAP4K2 | 1.31340349 |
| 40 | RIPK4 | 1.28425857 |
| 41 | MAP2K6 | 1.27018178 |
| 42 | TNIK | 1.25526171 |
| 43 | UHMK1 | 1.25224118 |
| 44 | PRPF4B | 1.18472524 |
| 45 | MKNK2 | 1.17236643 |
| 46 | MAPKAPK3 | 1.14923233 |
| 47 | GRK5 | 1.13160752 |
| 48 | FES | 1.13048433 |
| 49 | PRKCG | 1.11860065 |
| 50 | SGK223 | 1.08366328 |
| 51 | SGK494 | 1.08366328 |
| 52 | MAP3K13 | 1.06639206 |
| 53 | PRKCH | 1.06579075 |
| 54 | ARAF | 1.05386841 |
| 55 | STK38L | 1.04049839 |
| 56 | CAMK1 | 1.03085078 |
| 57 | TLK1 | 0.99901149 |
| 58 | STK11 | 0.98011944 |
| 59 | RET | 0.97878925 |
| 60 | LMTK2 | 0.94771291 |
| 61 | PNCK | 0.94392801 |
| 62 | PHKG2 | 0.92553775 |
| 63 | PHKG1 | 0.92553775 |
| 64 | SGK2 | 0.92210750 |
| 65 | SGK3 | 0.89507941 |
| 66 | PINK1 | 0.88595843 |
| 67 | DYRK2 | 0.88444123 |
| 68 | MARK2 | 0.85499735 |
| 69 | CAMK1G | 0.83274062 |
| 70 | PLK2 | 0.80489100 |
| 71 | CAMK2A | 0.79749231 |
| 72 | CDK18 | 0.79343220 |
| 73 | PIK3CA | 0.78381693 |
| 74 | PAK3 | 0.78135705 |
| 75 | RIPK1 | 0.77567868 |
| 76 | CDK15 | 0.76427804 |
| 77 | CSNK1G2 | 0.74695438 |
| 78 | MAP3K1 | 0.73785242 |
| 79 | SIK3 | 0.72992972 |
| 80 | ALK | 0.72048307 |
| 81 | CDK14 | 0.71818796 |
| 82 | OXSR1 | 0.71520412 |
| 83 | DYRK1A | 0.70560754 |
| 84 | TNK2 | 0.69339673 |
| 85 | SGK1 | 0.68482461 |
| 86 | ADRBK1 | 0.67366358 |
| 87 | PDK1 | 0.67013867 |
| 88 | CSNK1G3 | 0.66454040 |
| 89 | PDPK1 | 0.65862572 |
| 90 | CDK11A | 0.65779028 |
| 91 | INSRR | 0.65480713 |
| 92 | FGFR2 | 0.65012259 |
| 93 | CDC42BPA | 0.64834599 |
| 94 | PRKCI | 0.64337849 |
| 95 | PRKCZ | 0.62730964 |
| 96 | NEK6 | 0.61501932 |
| 97 | CAMK2B | 0.60493820 |
| 98 | WNK1 | 0.57931842 |
| 99 | RAF1 | 0.57659377 |
| 100 | TAOK3 | 0.57444882 |
| 101 | ERBB3 | 0.56977694 |
| 102 | CSNK1A1 | 0.56500742 |
| 103 | CSNK1G1 | 0.56038571 |
| 104 | CAMK4 | 0.55473849 |
| 105 | LATS2 | 0.55371089 |
| 106 | BMPR2 | 0.54397813 |
| 107 | FER | 0.51606837 |
| 108 | RPS6KA3 | 0.50804292 |
| 109 | PRKAA1 | 0.50744479 |
| 110 | CSNK1A1L | 0.49654014 |
| 111 | FYN | 0.49042344 |
| 112 | MAP3K7 | 0.48521068 |
| 113 | RPS6KA2 | 0.47557702 |
| 114 | HIPK2 | 0.45824533 |
| 115 | PRKCE | 0.45151888 |
| 116 | TRIM28 | 0.43895393 |
| 117 | CHUK | 0.43839455 |
| 118 | RPS6KB2 | 0.43374665 |
| 119 | TSSK6 | 0.42610294 |
| 120 | MAPK10 | 0.42504133 |
| 121 | CAMK2G | 0.39741751 |
| 122 | EPHA3 | 0.39334259 |
| 123 | PRKAA2 | 0.37861644 |
| 124 | TRIB3 | 0.37341874 |
| 125 | CSNK1D | 0.36263421 |
| 126 | PTK2B | 0.36005944 |
| 127 | RPS6KA6 | 0.35524748 |
| 128 | MELK | 0.35467394 |
| 129 | WNK3 | 0.35307819 |
| 130 | MAPK12 | 0.34861567 |
| 131 | MAPKAPK5 | 0.34776048 |
| 132 | MAP2K1 | 0.34493733 |
| 133 | CCNB1 | 0.34438505 |
| 134 | CAMK2D | 0.32343061 |
| 135 | PRKCB | 0.32171590 |
| 136 | SCYL2 | 0.31988302 |
| 137 | AKT3 | 0.31753621 |
| 138 | MUSK | 0.29355374 |
| 139 | IRAK1 | 0.28656382 |
| 140 | PKN2 | 0.28046637 |
| 141 | WNK4 | 0.27031932 |
| 142 | RPS6KB1 | 0.26593832 |
| 143 | PRKACA | 0.24857602 |
| 144 | MST4 | 0.24256982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.32044776 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.13175266 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.69854339 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.54826871 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54125203 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.53260847 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.40593448 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.39629814 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.37333926 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.35555742 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.26860620 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.24851248 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.16321620 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 2.15712101 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14510069 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05480480 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.02467562 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 2.01824914 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.93806756 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.89973249 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.88141716 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.86771442 |
| 23 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.83659870 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83248868 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.73562102 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61444346 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.59355074 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58082501 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54766084 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.52500493 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51183561 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50516296 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48319035 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.47950202 |
| 35 | Long-term depression_Homo sapiens_hsa04730 | 1.45406086 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45262573 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.45017796 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.44039292 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32531814 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32232653 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 1.29531717 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28680973 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26197548 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24970265 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24424210 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23276490 |
| 47 | Gap junction_Homo sapiens_hsa04540 | 1.21901044 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21801022 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18018450 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13686394 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11652979 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09431689 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07760042 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03964564 |
| 55 | Glioma_Homo sapiens_hsa05214 | 1.02447606 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.02273452 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01649257 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 0.97722511 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97245206 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97010062 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.93001127 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90402509 |
| 63 | Melanogenesis_Homo sapiens_hsa04916 | 0.88481447 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85360950 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85314357 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84392702 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84304413 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81662129 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80648632 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79775243 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79675910 |
| 72 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79145622 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.76462481 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74836200 |
| 75 | Protein export_Homo sapiens_hsa03060 | 0.74636835 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74532783 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72025839 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71439985 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70940997 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70679156 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69942633 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.68862843 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68516615 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66790246 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65780784 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63966076 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62510678 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62138849 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61537476 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.60791551 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60343237 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60295291 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58484440 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58298651 |
| 95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58240644 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57964069 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57237279 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57041628 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56536461 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55057191 |
| 101 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53583323 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53173278 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52792448 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51152147 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50626494 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50460730 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50348860 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49853469 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49484383 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.49375646 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48186393 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.47049997 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47027654 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46882833 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46518091 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46437354 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46298508 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45984113 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45922173 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.45507274 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.45467530 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45440734 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45423760 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44841027 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44607313 |
| 126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43970778 |
| 127 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43802803 |
| 128 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43733065 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43541146 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.43371771 |
| 131 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42930712 |
| 132 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38340043 |
| 133 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38318246 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36669549 |
| 135 | RNA degradation_Homo sapiens_hsa03018 | 0.35858793 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35484895 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35038860 |
| 138 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34106184 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33302563 |
| 140 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32626260 |
| 141 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32251427 |
| 142 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31875612 |
| 143 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29283624 |
| 144 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28946658 |
| 145 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28274269 |

